(GILD) Gilead Sciences - Performance 70.8% in 12m
GILD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
70.97%
#4 in Peer-Group
Rel. Strength
90.24%
#751 in Stock-Universe
Total Return 12m
70.81%
#20 in Peer-Group
Total Return 5y
82.77%
#15 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 23.5 |
| P/E Forward | 14.1 |
| High / Low | USD |
|---|---|
| 52 Week High | 115.77 USD |
| 52 Week Low | 64.61 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 68.40 |
| Buy/Sell Signal +-5 | 0.53 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GILD (70.8%) vs XBI (-10.3%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.38% | 70.8% | 82.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.6% | -8.36% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.02% | -2.91% | 36% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.49% | 30.5% | -2.72% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
1.71% | -10.1% | -2.8% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.6% | 38.9% | -7.13% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.18% | 51.2% | -15.7% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.97% | 30.4% | 16.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: GILD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GILD
| Total Return (including Dividends) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.38% | -0.81% | 3.81% |
| 3 Months | 6.68% | 14.52% | 23.42% |
| 12 Months | 70.81% | -10.32% | 13.17% |
| 5 Years | 82.77% | -27.72% | 112.04% |
| Trend Score (consistency of price movement) | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.6% | -6.5% | 81% |
| 3 Months | 73.4% | 79.4% | 97.3% |
| 12 Months | 92.5% | -86.4% | 45.1% |
| 5 Years | 84.2% | -52.3% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th63.50 | 0.44% | -4.03% |
| 3 Month | %th38.00 | -6.84% | -13.56% |
| 12 Month | %th91.00 | 90.47% | 50.93% |
| 5 Years | %th94.00 | 152.87% | -13.80% |
FAQs
Does Gilead Sciences (GILD) outperform the market?
Yes,
over the last 12 months GILD made 70.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.32%.
Over the last 3 months GILD made 6.68%, while XBI made 14.52%.
Performance Comparison GILD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GILD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.4% | -4.2% | 19% | 58% |
| US NASDAQ 100 | QQQ | 0.8% | -4.5% | 17.7% | 59% |
| German DAX 40 | DAX | 0.3% | 0.1% | 7.2% | 41% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.4% | -3% | 17% | 51% |
| Hongkong Hang Seng | HSI | 1% | -3% | 0.7% | 32% |
| India NIFTY 50 | INDA | 1.4% | -0.6% | 19.5% | 72% |
| Brasil Bovespa | EWZ | 1.7% | -5.9% | -0.6% | 63% |
GILD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.2% | -4.1% | 15.1% | 46% |
| Consumer Discretionary | XLY | 0.3% | -2.7% | 26.4% | 54% |
| Consumer Staples | XLP | -0.6% | -1.7% | 17.5% | 62% |
| Energy | XLE | -0.8% | -4.4% | 25.5% | 71% |
| Financial | XLF | 0.2% | -4% | 15.3% | 42% |
| Health Care | XLV | 1.1% | -1% | 28.1% | 76% |
| Industrial | XLI | -0.1% | -3.5% | 11.8% | 46% |
| Materials | XLB | -2.2% | -3.3% | 15.9% | 66% |
| Real Estate | XLRE | 0.7% | -0.4% | 19.7% | 59% |
| Technology | XLK | 0.2% | -7% | 15.8% | 61% |
| Utilities | XLU | 0.4% | -2.8% | 15.7% | 48% |
| Aerospace & Defense | XAR | 1.4% | -4.9% | -0.5% | 22% |
| Biotech | XBI | 0% | 0.4% | 35.1% | 81% |
| Homebuilder | XHB | -1.8% | -5.7% | 26.6% | 68% |
| Retail | XRT | -2.9% | -2.1% | 23.9% | 61% |
GILD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.8% | -6.53% | 27.2% | 76% |
| Natural Gas | UNG | 1.9% | 8.4% | 30.6% | 76% |
| Gold | GLD | -0% | -0.6% | -0.6% | 30% |
| Silver | SLV | -1.1% | -0.5% | 2.8% | 52% |
| Copper | CPER | 2.4% | -1.9% | 6.2% | 62% |
GILD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.9% | -1.6% | 22.7% | 74% |
| iShares High Yield Corp. Bond | HYG | 1% | -1.8% | 20.5% | 61% |